F P Costa

Summary

Publications

  1. ncbi Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours
    F P Costa
    Centro de Oncologia, Hospital Sirio Libanes, Rua Dona Adma Jafet 90, Sao Paulo, SP, CEP 01308 050, Brazil Electronic address
    Best Pract Res Clin Gastroenterol 26:843-54. 2012
  2. ncbi Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan® in two cases
    Rachel Jorge D Cossetti
    Centro de Oncologia, Hospital Sirio Libanes, Rua Dona Adma Jafet 91, São Paulo 01308 050, Brazil
    World J Surg Oncol 10:82. 2012
  3. ncbi Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach
    Alexandre Barbault
    Cabinet medical, Avenue de la Gare 6, Lausanne, Switzerland
    J Exp Clin Cancer Res 28:51. 2009
  4. ncbi Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields
    F P Costa
    Department of Transplantation and Liver Surgery, Hospital das Clinicas da Faculdade de Medicina, University of Sao Paulo, Av Dr Eneas de Carvalho Aguiar, 255, São Paulo 05403 000, Brazil
    Br J Cancer 105:640-8. 2011

Collaborators

  • Rachel Jorge D Cossetti
  • Alexandre Barbault
  • Regis Otaviano França Bezerra
  • Brenda Gumz
  • Adriana Telles
  • Brad Bottger
  • Fin Bomholt
  • Reginald F Munden
  • Niels Kuster
  • Boris Pasche

Detail Information

Publications4

  1. ncbi Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours
    F P Costa
    Centro de Oncologia, Hospital Sirio Libanes, Rua Dona Adma Jafet 90, Sao Paulo, SP, CEP 01308 050, Brazil Electronic address
    Best Pract Res Clin Gastroenterol 26:843-54. 2012
    ..In this report we provide treatment recommendations to improve systemic therapy in patients with advanced GEP-NETs based on a comprehensive review of the literature...
  2. ncbi Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan® in two cases
    Rachel Jorge D Cossetti
    Centro de Oncologia, Hospital Sirio Libanes, Rua Dona Adma Jafet 91, São Paulo 01308 050, Brazil
    World J Surg Oncol 10:82. 2012
    ..In this article we report the use of DWI in MRI and WBD in two cases of metastatic pulmonary NET staging in comparison with OctreoScan® in order to illustrate the potential advantage of DWI and WBD in staging NETs...
  3. ncbi Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach
    Alexandre Barbault
    Cabinet medical, Avenue de la Gare 6, Lausanne, Switzerland
    J Exp Clin Cancer Res 28:51. 2009
    ..We undertook this study to identify tumor-specific frequencies and test the feasibility of administering such frequencies to patients with advanced cancer...
  4. ncbi Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields
    F P Costa
    Department of Transplantation and Liver Surgery, Hospital das Clinicas da Faculdade de Medicina, University of Sao Paulo, Av Dr Eneas de Carvalho Aguiar, 255, São Paulo 05403 000, Brazil
    Br J Cancer 105:640-8. 2011
    ..There is emerging evidence that the growth of cancer cells may be altered by very low levels of electromagnetic fields modulated at specific frequencies...